These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23836971)

  • 81. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.
    de Oliveira Eloy J; Saraiva J; de Albuquerque S; Marchetti JM
    AAPS PharmSciTech; 2012 Dec; 13(4):1436-45. PubMed ID: 23070562
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
    Vadia N; Rajput S
    Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
    Yasmin R; Tan A; Bremmell KE; Prestidge CA
    J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
    Pokharkar V; Kutwal M; Mandpe L
    PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage.
    Weuts I; Kempen D; Verreck G; Peeters J; Brewster M; Blaton N; Van den Mooter G
    Eur J Pharm Sci; 2005; 25(4-5):387-93. PubMed ID: 15894472
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Characterization and Dissolution Mechanism of Low-Molecular-Weight Organic Acids or Inorganic Mesoporous Particle-Based Piperine Amorphous Solid Dispersions.
    Li Y; Zhang Q; Yu N; Peng L; Gao Q; Li L; Zhao J; Yang J
    Langmuir; 2024 Jul; 40(29):14941-14952. PubMed ID: 38980061
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation.
    Han HK; Lee BJ; Lee HK
    Int J Pharm; 2011 Aug; 415(1-2):89-94. PubMed ID: 21645596
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
    Ashour AA; El-Kamel AH; Abdelmonsif DA; Khalifa HM; Ramadan AA
    Int J Nanomedicine; 2021; 16():8013-8033. PubMed ID: 34916792
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.
    Yang L; Shao Y; Han HK
    Int J Nanomedicine; 2016; 11():1067-76. PubMed ID: 27042061
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A promising nanomatrix system of simvastatin for oral delivery: Evaluation in vitro and in vivo.
    He S; Duan L; Li Y; Cui Z; Zhang X
    Pak J Pharm Sci; 2020 Nov; 33(6):2489-2495. PubMed ID: 33867321
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.
    Li J; Liu P; Liu JP; Zhang WL; Yang JK; Fan YQ
    Eur J Pharm Biopharm; 2012 Feb; 80(2):426-32. PubMed ID: 22119664
    [TBL] [Abstract][Full Text] [Related]  

  • 94. pH-independent dissolution enhancement for multiple poorly water-soluble drugs by nano-sized solid dispersions based on hydrophobic-hydrophilic conjugates.
    Tran CTM; Tran PHL; Tran TTD
    Drug Dev Ind Pharm; 2019 Mar; 45(3):514-519. PubMed ID: 30575412
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Improved transdermal permeability of tanshinone IIA from cataplasms by loading onto nanocrystals and porous silica.
    Gu X; Guo J; Mai Y; Niu Y; Chen J; Zhao Q; Yang J
    Pharm Dev Technol; 2021 Dec; 26(10):1061-1072. PubMed ID: 34511025
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Glabridin smartPearls - Silica selection, production, amorphous stability and enhanced solubility.
    Hespeler D; Kaltenbach J; Pyo SM
    Int J Pharm; 2019 Apr; 561():228-235. PubMed ID: 30836152
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
    Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
    Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion.
    Rashid R; Kim DW; Din FU; Mustapha O; Yousaf AM; Park JH; Kim JO; Yong CS; Choi HG
    Carbohydr Polym; 2015 Oct; 130():26-31. PubMed ID: 26076597
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole.
    Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ
    Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.